|
1
|
Todosi AM, Gavrilescu MM, Aniţei GM, et
al: Colon cancer at the molecular level - usefulness of
epithelial-mesenchymal transition analysis. Rev Med Chir Soc Med
Nat Iasi. 116:1106–1111. 2012.
|
|
2
|
Wallace PM and Suzuki R: Regional, racial,
and gender differences in colorectal cancer screening in
middle-aged African-Americans and Whites. J Cancer Educ.
27:703–708. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zauber AG, Winawer SJ, O’Brien MJ, et al:
Colonoscopic polypectomy and long-term prevention of
colorectal-cancer deaths. N Engl J Med. 366:687–696. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nagasaka T, Mori Y, Umeda Y and Fujiwara
T: Biomarker for colorectal cancer. Nihon Rinsho. 70:802–808.
2012.(In Japanese). PubMed/NCBI
|
|
5
|
Imperiale TF, Ransohoff DF, Itzkowitz SH,
et al: Fecal DNA versus fecal occult blood for colorectal-cancer
screening in an average-risk population. N Engl J Med.
351:2704–2714. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sonnenberg A and Delcò F:
Cost-effectiveness of a single colonoscopy in screening for
colorectal cancer. Arch Intern Med. 162:163–168. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lind GE, Danielsen SA, Ahlquist T, et al:
Identification of an epigenetic biomarker panel with high
sensitivity and specificity for colorectal cancer and adenomas. Mol
Cancer. 10:852011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mori Y, Olaru AV, Cheng Y, et al: Novel
candidate colorectal cancer biomarkers identified by methylation
microarray-based scanning. Endocr Relat Cancer. 18:465–478. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jin X, Lin M, Zhang H, et al: Serum
biomarkers of colorectal cancer with AU and NP20 chips including a
diagnosis model. Hepatogastroenterology. 59:124–129.
2012.PubMed/NCBI
|
|
10
|
Lenhard K, Bommer GT, Asutay S, et al:
Analysis of promoter methylation in stool: a novel method for the
detection of colorectal cancer. Clin Gastroenterol Hepatol.
3:142–149. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lange CP, Campan M, Hinoue T, et al:
Genome-scale discovery of DNA-methylation biomarkers for
blood-based detection of colorectal cancer. PloS One. 7:e502662012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cassinotti E, Melson J, Liggett T, et al:
DNA methylation patterns in blood of patients with colorectal
cancer and adenomatous colorectal polyps. Int J Cancer.
131:1153–1157. 2012. View Article : Google Scholar :
|
|
13
|
Lange CP and Laird PW: Clinical
applications of DNA methylation biomarkers in colorectal cancer.
Epigenomics. 5:105–108. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ahlquist DA, Zou H, Domanico M, et al:
Next-generation stool DNA test accurately detects colorectal cancer
and large adenomas. Gastroenterology. 142:248–256. 2012. View Article : Google Scholar
|
|
15
|
Yamamoto H, Kokame K, Okuda T, et al:
NDRG4 protein-deficient mice exhibit spatial learning deficits and
vulnerabilities to cerebral ischemia. J Biol Chem. 286:26158–26165.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Melotte V, Lentjes MH, van den Bosch SM,
et al: N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor
suppressor gene and potential biomarker for colorectal cancer. J
Natl Cancer Inst. 101:916–927. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kotipatruni RP, Ferraro DJ, Ren X, et al:
NDRG4, the N-Myc downstream regulated gene, is important for cell
survival, tumor invasion and angiogenesis in meningiomas. Integr
Biol (Camb). 4:1185–1197. 2012. View Article : Google Scholar
|
|
18
|
Fan LP, Shen JZ, Ye BG, et al: Detection
of p16 gene methylation status in adult patients with acute
leukemia by using n-MSP. Zhongguo Shi Yan Xue Ye Xue Za Zhi.
15:258–261. 2007.PubMed/NCBI
|
|
19
|
Carraway HE, Wang S, Blackford A, et al:
Promoter hypermethylation in sentinel lymph nodes as a marker for
breast cancer recurrence. Breast Cancer Res Treat. 114:315–325.
2009. View Article : Google Scholar
|
|
20
|
Ryan HE, Lo J and Johnson RS: HIF-1 alpha
is required for solid tumor formation and embryonic
vascularization. EMBO J. 17:3005–3015. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yi JM, Dhir M, Guzzetta AA, et al: DNA
methylation biomarker candidates for early detection of colon
cancer. Tumour Biol. 33:363–372. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ziyab AH, Karmaus W, Holloway JW, et al:
DNA methylation of the filaggrin gene adds to the risk of eczema
associated with loss-of-function variants. J Eur Acad Dermatol
Vernereol. 27:e420–e423. 2013. View Article : Google Scholar
|
|
23
|
Morioka Y, Hibi K, Sakai M, et al:
Aberrant methylation of the CHFR gene in digestive tract cancer.
Anticancer Res. 26:1791–1795. 2006.PubMed/NCBI
|
|
24
|
de la Chapelle A and Hampel H: Clinical
relevance of microsatellite instability in colorectal cancer. J
Clin Oncol. 28:3380–3387. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Uehara E, Takeuchi S, Yang Y, et al:
Aberrant methylation in promoter-associated CpG islands of multiple
genes in chronic myelogenous leukemia blast crisis. Oncol Lett.
3:190–192. 2012.PubMed/NCBI
|
|
26
|
Zhao YF, Zhang YG, Tian XX, Juan D and Jie
Z: Aberrant methylation of multiple genes in gastric carcinomas.
Int J Surg Pathol. 15:242–251. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Samejima K, Hiramatsu K, Takahashi K, et
al: Identification and determination of urinary acetylpolyamines in
cancer patients by electrospray ionization and time-of-flight mass
spectrometry. Anal Biochem. 401:22–29. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cai H, Thomasset SC, P-Berry D, et al:
Determination of anthocyanins in the urine of patients with
colorectal liver metastases after administration of bilberry
extract. Biomed Chromatogr. 25:660–663. 2011. View Article : Google Scholar
|
|
29
|
Jackson C, Best N and Elliott P: UK
Biobank Pilot Study: stability of haematological and clinical
chemistry analytes. Int J Epidemiol. 37(Suppl 1): i16–i22. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ahlquist DA, Taylor WR, Mahoney DW, et al:
The stool DNA test is more accurate than the plasma septin 9 test
in detecting colorectal neoplasia. Clin Gastroenterol Hepatol.
10:272–277. 2012. View Article : Google Scholar
|
|
31
|
deVos T, Tetzner R, Model F, et al:
Circulating methylated SEPT9 DNA in plasma is a biomarker for
colorectal cancer. Clin Chem. 55:1337–1346. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lacks S and Greenberg B: Complementary
specificity of restriction endonucleases of Diplococcus pneumoniae
with respect to DNA methylation. J Mol Biol. 114:153–168. 1977.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hastings ML, Palma J and Duelli DM:
Sensitive PCR-based quantitation of cell-free circulating
microRNAs. Methods. 58:144–150. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ding W, Zhang J, Yoon JG, Shi D, Foltz G
and Lin B: NDRG4 is downregulated in glioblastoma and inhibits cell
proliferation. OMICS. 16:263–267. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang X, An L and Li X: NDRG3 and NDRG4,
two novel tumor-related genes. Biomed Pharmacother. 67:681–684.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hayashi T, Yoshikawa T, Bonam K, et al:
The superiority of the seventh edition of the TNM classification
depends on the overall survival of the patient cohort: comparative
analysis of the sixth and seventh TNM editions in patients with
gastric cancer from Japan and the United Kingdom. Cancer.
119:1330–1337. 2013. View Article : Google Scholar : PubMed/NCBI
|
